Objectives: i) To review the methacholine tests performed in our Laboratory up until 2008; ii) to compare them with previously reported data in 2006 and iii) to examine if the Anti-Doping rules are meeting the needs of asthmatic athletes who really need bronchodilator treatment.
Methods: Between April 2004 and September 2008, 89 high level athletes were examined in our laboratory in order to obtain an ATUE for beta 2 agonists. Of these, 50 men (23.31 ± 7.05 years) and 23 women (20.68 ± 5.94 years) performed a methacholine inhalation test with increasing concentrations of methacholine (0,025 mg/ml, 0,25 mg/ml, 2,5 mg/ml, 5 mg/ml, 10 mg/ml and 25 mg/ml) until a fall of 20% in FEV1 was achieved.
Results: 31 candidates (42.5%) had a PC20 lower than 2 mg/mL; 12 (16.4%) were between 2 and 4 mg/mL; 8 (11%) between 4.1 and 8 mg/mL and 22 candidates (30.1%) had a PC20 higher than 8 mg/mL. Seven of the 73 candidates had an obstructive pattern in the spirometry at rest, demonstrated by a FEV1% lower than 70% but with a FEV1 higher than 70% of the reference value.
Conclusions: The anti-doping regulations with respect to beta-2 agonists need to be reviewed and measures should be adopted to include a fall of 70% in FEV1% as an obstruction criterion to indicate a bronchodilation test and to extend the criterion for a positive methacholine test to a PC20 of 8 mg/ml.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.